Vitality Watch

Dossier pubmed preclinical 13-jul-2026
Animal model, organoid, or cell-culture result — not yet human

Nanoparticles as an efficient strategy to eliminate senescent brain endothelial cells.

Key claim: Navitoclax-loaded polymeric nanoparticles selectively kill senescent brain endothelial cells, reduce BBB permeability, clear p16/p21-positive BECs, and partially restore exploratory behavior in naturally aged rats more effectively than high-dose soluble Navitoclax.

Abstract

The blood-brain barrier (BBB) experiences dysfunction during physiological aging, potentially leading to cognitive decline and the onset of neurodegenerative diseases. Recent research highlights brain endothelial cell (BEC) senescence as a key factor contributing to BBB impairment. In this study, polymeric nanoparticles (NPs) loaded with a senolytic agent - Navitoclax - were designed to selectively eliminate senescent cells more effectively. These NPs are taken up by both proliferative and senescent BECs, but are only degraded in the latter due to the presence of senescence-associated beta-galactosidase (SA-β-gal), releasing the drug to induce cell death. NPs effectively and selectively eliminate senescent BECs at lower doses, without affecting proliferative cells, outperforming the soluble senolytic. NPs were then evaluated in a chronologically aged rat model exhibiting BEC senescence, increased BBB permeability, and diminished exploratory behavior. In comparison to high-dose soluble senolytic, the NPs successfully restored BBB integrity by reducing permeability, diminishing the burden of senescent BECs, and partially improving rat exploratory performance. Notably, only the NPs were able to reduce the presence of p21and p16BECs in vivo and enhance exploratory behavior. These findings suggest that NPs containing senolytics represent a promising intervention for decreasing BECs senescence, reducing BBB permeability, and enhancing exploratory behavior in naturally aged rats.

Why this matters

The finding adds cerebrovascular endothelium to the growing roster of tissue-specific senescence compartments where targeted-delivery senolytics (nanoparticles, biomimetic carriers, aptamer-DNAzymes) outperform free drug at lower doses. It also couples senescent-cell clearance to a functional BBB and behavioral readout in chronologically aged (not just accelerated-aging) rodents, an animal-model tier data point on whether cerebrovascular senescence is causally upstream of BBB leak and cognition.

Source

Link

Briefing card

Nanoparticles as an efficient strategy to eliminate senescent brain endothelial cells.
Stage: preclinical · pubmed · 13-jul-2026

Applies to preclinical navitoclax programs: a nanoparticle formulation cleared senescent brain endothelial cells and reduced BBB leakage in aged rats at doses below the free-drug regimen.

Navitoclax-loaded polymeric nanoparticles selectively kill senescent brain endothelial cells, reduce BBB permeability, clear p16/p21-positive BECs, and partially restore exploratory behavior in naturally aged rats more effectively than high-dose soluble Navitoclax.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.jconrel.2026.115174

build build 880 · 2bcef25 · 2026-11-18